By Mike Scarcella | April 30, 2020
"Notwithstanding this dispute, Gilead will continue to work with federal agencies, including HHS and the CDC," Gilead, represented by a team from Wilmer Cutler Pickering Hale and Dorr, including former U.S. Attorney Ronald Machen Jr., said in announcing the new lawsuit.
By Scott Graham | March 4, 2020
A non-traditional pharma case brought by non-traditional pharma litigators is shaping up to make significant antitrust law for the industry.
By Amanda Bronstad | February 25, 2020
Mallinckrodt's "settlement framework" resolves thousands of claims brought by cities and counties in the multidistrict litigation. California Attorney General Xavier Becerra called the deal "a step in the right direction."
By Frances Rogers and Kate S. Im | February 20, 2020
Senate Bill 223, also known as Jojo's Act, permits school districts, county boards of education, and charter schools maintaining kindergarten or any grades 1 to 12, to adopt a policy allowing a parent or guardian to administer medical marijuana to their student who is a "qualified patient" on school grounds.
By Alaina Lancaster | February 5, 2020
Alameda County Superior Court Judge Winifred Smith is likely to deny Bayer's motion to seal internal audit documents, having ruled tentatively that California law does not protect self-critical analysis from public disclosure.
By Ross Todd | January 13, 2020
Stacy Amin, chief counsel of the Food and Drug Administration, appeared by telephone Monday at a hearing in San Jose where federal prosecutors were asking to extend a court-ordered deadline for the agency to hand over a trove of documents requested by lawyers for Theranos founder Elizabeth Holmes and her co-defendant to April 30.
By Scott Graham | December 30, 2019
The Pfizer subsidiary argued that the threat of harm, even if years in the future, should be grounds for an injunction. But Fenwick & West partner Jedediah Wakefield had argued for Loxo Oncology that Array was merely speculating.
By Scott Graham | December 27, 2019
The justices have scheduled six Section 101 cases for votes on Jan. 10. They include a medical diagnostics case that the solicitor general says the court should use to overhaul the law of patent eligibility. HP Inc. and Hikma Pharmaceuticals argue that their cases ought to at least go along for the ride.
By Scott Graham | December 17, 2019
The IP litigator led a team of Irell & Manella and Jones Day attorneys in an eight-day trial on behalf of Juno Therapeutics and Memorial Sloan-Kettering Cancer Center. The companies had accused Kite Pharma of infringing a patent on ground-breaking CAR T immunotherapy.
By Scott Graham | December 11, 2019
The decision made a winner of Irell & Manella partner Morgan Chu in his first argument to the Supreme Court and his California-based client, cancer treatment startup NantKwest.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The Daily Report is honoring those attorneys and judges who have made a remarkable difference in the legal profession.
Consulting Magazine identifies consultants that have the biggest impact on their clients, firms and the profession.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Company Description CourtLaw Injury Lawyers is an established Personal Injury Law Firm with its primary office located in Perth Amboy, New J...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS